← TruNorth

ALNYLAM PHARMACEUTICALS vs Entrada Therapeutics

On overall TruNorth grade, Entrada Therapeutics scores higher (ALNYLAM PHARMACEUTICALS: C, Entrada Therapeutics: B). Both graded from public records across nine values categories.

C
ALNYLAM PHARMACEUTICALS
54.5/100
B
Entrada Therapeutics
61.7/100

Political donations

ALNYLAM PHARMACEUTICALS

FEC: $52K PAC donations; 62% to Republican, 38% to Democratic committees.

Entrada Therapeutics

FEC: $281K in executive political donations; partisan lean split across 12 executive donors.

Environment

ALNYLAM PHARMACEUTICALS

No public record found.

Entrada Therapeutics

No public record found.

Labor

ALNYLAM PHARMACEUTICALS

2 federal penalties totaling $202K since 2000 (Violation Tracker).

Entrada Therapeutics

No public record found.

DEI

ALNYLAM PHARMACEUTICALS

EEO-1 workforce demographics on federal record (FY2020, DOL OFCCP FOIA release): 1,138 US employees — 49% women, 31.9% racial/ethnic minorities; management 47.9% women, 27.2% minorities.

Entrada Therapeutics

No public record found.

Charity

ALNYLAM PHARMACEUTICALS

No public record found.

Entrada Therapeutics

No public record found.

Animal testing

ALNYLAM PHARMACEUTICALS

No public record found.

Entrada Therapeutics

No public record found.

Firearms

ALNYLAM PHARMACEUTICALS

No public record found.

Entrada Therapeutics

No public record found.

Privacy

ALNYLAM PHARMACEUTICALS

No public record found.

Entrada Therapeutics

No public record found.

Executive pay

ALNYLAM PHARMACEUTICALS

CEO-to-median-worker pay ratio 48:1 (median employee pay $312,180; CEO total compensation $25K) — SEC proxy statement (DEF 14A, 2025).

Entrada Therapeutics

No public record found.

Compare any two brands on the values you care about — personalized to your 30-second quiz.

Open TruNorth →